Atento SA (ATTO) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$22.51

From 52W high−13.35%

Volume1.35M

Market cap$1.01B

P/E (TTM)—

P/S (TTM)748.7x

Div yield—

Key dataSep 18, 2026

Open

$22.51

From 52W high

−13.35%

Volume

1.35M

Market cap

$1.01B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−17.5x

P/E (TTM)

—

RSI (14)

56.0

MomentumView details →

1D Return

−2.60%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−17.5x

EV/Sales

857.9x

P/S (TTM)

748.7x

P/B (TTM)

9.0x

ProfitabilityView details →

Gross Margin

40.44%

Net Margin

−4490.89%

EBITDA Margin

−4915.19%

ROE (TTM)

−53.76%

ROA (TTM)

−47.24%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−35.24%

EBITDA YoY

—

MomentumView details →

1D Return

−2.60%

YTD Return

—

1Y Return

—

RSI (14)

56.0

vs 50D SMA

—

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.04x

Current Ratio

9.39x

Quick Ratio

9.39x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$4.88

EPS Surprise

−655.53%

Beats (12Q)

0/12

Next Q EPS Est

−$0.56

Avg Surprise (4Q)

−655.53%

Rev Surprise

42.11%

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for ATTO.

Similar companies

Adlai Nortye Ltd.ANL Janux Therapeutics, Inc.JANX Alumis Inc. Common StockALMS Ventyx Biosciences, Inc.VTYX Arbutus Biopharma CorporationABUS Monte Rosa Therapeutics, Inc.GLUE Find similar companies →

Latest newsMore news →

No recent news for ATTO.